إعلان
إعلان

ZYME

ZYME logo

Zymeworks Inc.

23.18
USD
برعاية
+0.08
+0.34%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

23.95

+0.77
+3.30%

تقارير أرباح ZYME

النسبة الإيجابية المفاجئة

ZYME تفوق 23 من 34 آخر التقديرات.

68%

التقرير التالي

بيانات التقرير القادم
٠٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$14.13M
/
-$0.43
التغير الضمني من Q3 25 (Revenue/ EPS)
-48.84%
/
+65.38%
التغير الضمني من Q4 24 (Revenue/ EPS)
-54.48%
/
+38.71%

Zymeworks Inc. earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, ZYME reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 20.63% surprise. Revenue reached 27.61 مليون, compared to an expected 30.05 مليون, with a -8.10% difference. The market reacted with a -8.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 المحللين forecast an EPS of -0.43 USD, with revenue projected to reach 14.13 مليون USD, implying an زيادة of 65.38% EPS, and نقصان of -48.84% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Zymeworks Inc. reported EPS of -$0.26, beating estimates by 20.63%, and revenue of $27.61M, -8.1% below expectations.
The stock price moved down -8.04%, changed from $17.90 before the earnings release to $16.46 the day after.
The next earning report is scheduled for ٠٣ مارس ٢٠٢٦.
Based on 14 المحللين, Zymeworks Inc. is expected to report EPS of -$0.43 and revenue of $14.13M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان